pAAV-Vector-AIO-System-rh74-CMV-EGFP(CAT#: GTV-0426-YJ16)
Optimized for skeletal and cardiac muscle targeting, this integrated system produces AAVrh.74. It shows higher transduction levels in muscle tissues compared to other serotypes, making it ideal for muscle disorder gene therapy research via one plasmid.
| Summary | |
|---|---|
| Application | Muscle tissue targeting |
| Related Diseases | Duchenne Muscular Dystrophy (DMD) |
| System Type | All-in-One System |
| Product Format | Single Plasmid |
| Size | 10 μg; 100 μg; 1 mg; 10 mg |
| AAV Serotype | AAVrh74 |
| Promoter | CMV |
| Transgene Reporter | EGFP |
| AAV Genome Type | ssAAV |
| Notice to Purchaser | For research use only. Not for use in diagnostic or therapeutic procedures. |
| Spe | |
|---|---|
| ITRs | L-ITR (119 bp) + R-ITR (130 bp) |
| Plasmid Size | 15,167 bp |
| Bacterial Resistance | Kana |
| Storage | Long-term storage: ≤ -20°C (Stable for at least 12 months). |
| Shipping | Dry ice. |
| Synonyms | pAAV-AIO-rh74-CMV-EGFP; pAAV-S1-rh74-CMV-EGFP; pAIO-rh74-CMV-EGFP |
